CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts.
CVS Health Corporation is a diversified healthcare company that runs pharmacies and retail stores while offering various health services, such as prescription management, vaccinations, and diagnostic testing.
On October 24, UBS increased its price target on CVS Health Corporation from $79 to $96 and reiterated a Buy rating on the stock.
In its third-quarter 2025 earnings report, CVS Health Corporation posted revenues of $102.8 billion, marking a 7.8% increase compared to the previous year. The company generated $7.2 billion in cash flow from operations year-to-date and updated its full-year guidance to a range of $7.5 billion to $8.0 billion, up from the earlier estimate of at least $7.5 billion.
CVS Health Corporation is also recognized for its consistent dividend payments, having distributed regular dividends to shareholders since 1997. The company offers a quarterly dividend of $0.665 per share and has a dividend yield of 3.30%, as of October 29.
READ NEXT: 10 Best Dividend Stocks Under $10 to Invest in and 11 Best FTSE Dividend Stocks to Buy Right Now
